{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:05Z","timestamp":1791907205864,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81861148018"],"award-info":[{"award-number":["81861148018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81722044"],"award-info":[{"award-number":["81722044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91753115"],"award-info":[{"award-number":["91753115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21778049"],"award-info":[{"award-number":["21778049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["DST\/IMRCD\/BRICS\/PilotCall2\/GPCRArrSig\/2018 (G)"],"award-info":[{"award-number":["DST\/IMRCD\/BRICS\/PilotCall2\/GPCRArrSig\/2018 (G)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["18-54-80016"],"award-info":[{"award-number":["18-54-80016"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0508100"],"award-info":[{"award-number":["2018YFA0508100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09711002"],"award-info":[{"award-number":["2018ZX09711002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001403","name":"Indian Institute of Technology Kanpur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.tips.2021.04.006","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T08:21:41Z","timestamp":1620634901000},"page":"577-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Structural insights into ligand recognition and activation of angiotensin receptors"],"prefix":"10.1016","volume":"42","author":[{"given":"Haitao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Luginina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Mishin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithu","family":"Baidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Cherezov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.04.006_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2021.04.006_bb0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1751-7176.2011.00518.x","article-title":"Angiotensin receptor blockers: pharmacology, efficacy, and safety","volume":"13","author":"Taylor","year":"2011","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.tips.2021.04.006_bb0015","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2741\/3289","article-title":"The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor","volume":"14","author":"Porrello","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.tips.2021.04.006_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2021.04.006_bb0025","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(13)62337-5","article-title":"EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"383","author":"Rice","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.04.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb8368","article-title":"Distinct phosphorylation sites in a prototypical GPCR differently orchestrate \u03b2-arrestin interaction, trafficking, and signaling","volume":"6","author":"Dwivedi-Agnihotri","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2021.04.006_bb0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2019.03.044","article-title":"Human gain-of-function MC4R variants show signaling bias and protect against obesity","volume":"177","author":"Lotta","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.04.006_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of beta-arrestin- and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tips.2021.04.006_bb0045","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tibs.2014.10.001","article-title":"Emerging structural insights into biased GPCR signaling","volume":"39","author":"Shukla","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tips.2021.04.006_bb0050","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signalling and biased agonism in G protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tips.2021.04.006_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tem.2017.01.001","article-title":"Biased opioid receptor ligands: gain without pain","volume":"28","author":"Ranjan","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tips.2021.04.006_bb0060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"Beta-arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2021.04.006_bb0065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1124\/jpet.110.173005","article-title":"Selectively engaging beta-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance","volume":"335","author":"Violin","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2021.04.006_bb0070","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1074\/jbc.M112.442053","article-title":"Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode","volume":"288","author":"Fillion","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.04.006_bb0075","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","article-title":"Structure of the angiotensin receptor revealed by serial femtosecond crystallography","volume":"161","author":"Zhang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.04.006_bb0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","article-title":"Allosteric sodium in class A GPCR signaling","volume":"39","author":"Katritch","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tips.2021.04.006_bb0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci."},{"key":"10.1016\/j.tips.2021.04.006_bb0090","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.M115.689000","article-title":"Structural basis for ligand recognition and functional selectivity at angiotensin receptor","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.04.006_bb0095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2018.12.005","article-title":"Angiotensin analogs with divergent bias stabilize distinct receptor conformations","volume":"176","author":"Wingler","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.04.006_bb0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cell.2018.12.006","article-title":"Distinctive activation mechanism for angiotensin receptor revealed by a synthetic nanobody","volume":"176","author":"Wingler","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.04.006_bb0105","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1126\/science.aay9813","article-title":"Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR","volume":"367","author":"Wingler","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.04.006_bb0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-417197-8.00006-7","article-title":"Constitutive activity in the angiotensin II type 1 receptor: discovery and applications","volume":"70","author":"Unal","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.tips.2021.04.006_bb0115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev-biochem-060614-033910","article-title":"The molecular basis of G protein-coupled receptor activation","volume":"87","author":"Weis","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tips.2021.04.006_bb0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.aaz0326","article-title":"Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor","volume":"367","author":"Suomivuori","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.04.006_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcp.2018.04.021","article-title":"Angiotensin II cyclic analogs as tools to investigate AT1R biased signaling mechanisms","volume":"154","author":"St-Pierre","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2021.04.006_bb0130","doi-asserted-by":"crossref","first-page":"15835","DOI":"10.1074\/jbc.M114.627356","article-title":"Identification of distinct conformations of the angiotensin-II type 1 receptor associated with the Gq\/11 protein pathway and the beta-arrestin pathway using molecular dynamics simulations","volume":"290","author":"Cabana","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.04.006_bb0135","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1124\/mol.114.097337","article-title":"Characterization of angiotensin II molecular determinants involved in AT1 receptor functional selectivity","volume":"87","author":"Domazet","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2021.04.006_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002522","article-title":"Differential beta-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs","volume":"5","author":"Zimmerman","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tips.2021.04.006_bb0145","doi-asserted-by":"crossref","first-page":"26603","DOI":"10.1074\/jbc.M109.012922","article-title":"Activation induces structural changes in the liganded angiotensin II type 1 receptor","volume":"284","author":"Clement","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.04.006_bb0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature22035","article-title":"Structural basis for selectivity and diversity in angiotensin II receptors","volume":"544","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.04.006_bb0155","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2174\/1381612811319170003","article-title":"Angiotensin II type 1 and type 2 receptor-induced cell signaling","volume":"19","author":"Akazawa","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tips.2021.04.006_bb0160","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41594-018-0079-8","article-title":"Crystal structure of the human angiotensin II type 2 receptor bound to an angiotensin II analog","volume":"25","author":"Asada","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2021.04.006_bb0165","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.str.2019.12.003","article-title":"The crystal structure of angiotensin II type 2 receptor with endogenous peptide hormone","volume":"28","author":"Asada","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.tips.2021.04.006_bb0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20110036","article-title":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors","volume":"121","author":"Bosnyak","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.tips.2021.04.006_bb0175","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/cb500063y","article-title":"Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II","volume":"9","author":"Magnani","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2021.04.006_bb0180","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/glia.22355","article-title":"beta-arrestin 2-dependent activation of ERK1\/2 is required for ADP-induced paxillin phosphorylation at Ser(83) and microglia chemotaxis","volume":"60","author":"Lee","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.tips.2021.04.006_bb0185","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949886","article-title":"Key phosphorylation sites in GPCRs orchestrate the contribution of beta-Arrestin 1 in ERK1\/2 activation","volume":"21","author":"Baidya","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tips.2021.04.006_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat1631","article-title":"Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors","volume":"11","author":"Namkung","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tips.2021.04.006_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.sbi.2020.03.004","article-title":"Beyond structure: emerging approaches to study GPCR dynamics","volume":"63","author":"Gusach","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.tips.2021.04.006_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.sbi.2018.03.009","article-title":"Structural biology of G protein-coupled receptors: new opportunities from XFELs and cryoEM","volume":"51","author":"Ishchenko","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.tips.2021.04.006_bb0205","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.str.2020.03.004","article-title":"Breaking the Enigma Code of angiotensin II type 2 receptor signaling","volume":"28","author":"Sadybekov","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.tips.2021.04.006_bb0210","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1038\/s41598-020-68355-x","article-title":"The discovery of a new antibody for BRIL-fused GPCR structure determination","volume":"10","author":"Miyagi","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:16:35Z","timestamp":1778670995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721000766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0165614721000766"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.04.006","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural insights into ligand recognition and activation of angiotensin receptors","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}